Clinical Trial Update: Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures [Phase 3]

View source ↗

Summary

A Phase 3 trial of Remegal fixed-dose as adjunctive therapy for partial seizures has completed under sponsor Valexfarm.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Partial Seizures
• Epilepsy
• Partial Seizures
• Partial Seizures with Secondary Generalization
• Simple Partial Seizures

Drugs mentioned

• Remegal

Snippet

Sponsor: Valexfarm | Conditions: Epilepsy, Simple Partial Seizures | Phase 3 | Status: COMPLETED